Skip to main content

Table 3 Levels of activities and/or proteins associated to HDL of controls and BC patients

From: High density lipoproteins and oxidative stress in breast cancer

  Control BC patients Reference
Serum paraoxonase (PON, U/mL) 124.89 ± 21.70 42.99 ± 7.98 [55]
158.39 ± 23.04 96.44 ± 21 [92]
Serum arylesterase (ARE) (U/mL) 98.55 ± 18.82 54.51 ± 11.57 [55]
239.33 ± 32.98 159.75 ± 15.75 [92]
Plasma paraoxonase (PON)(U/mL) 95.00 ± 30.38 58.50 ± 1.67 [93]
Plasma arylesterase (ARE) (U/mL) 52.10 ± 11.98 65.00 ± 28.29
PON levels (μg/mL) 80.62 ± 02.56 58.50 ± 1.67
PON1 activity (U/L) 274.3 (156.8–565.9) 154.9 (99.9–260.2) [92]
PON1 concentration (mg/L) 97.3 (43.2–285.3) 91.7 (30.6–223.3)
Plasma LCAT (pg/ml) 5.98 ± 0.88 5.12 ± 0.58 [94]
Plasma PLA2 activity 1600 ± 100 1800 ± 100 [95]